Today we celebrate an expanded partnership with Pharm-Olam to accelerate digital transformation. "We picked the premier technology platform. We're very excited about this; we can't wait to take it to the next level" @Pharm_Olam
https://t.co/Wfds088xJ6
#LifeSciences#ClinicalTrial
Will we see you at #DIA2018? Don't miss the presentation by @Pharm_Olam on, ‘Why Portfolio Analysis Through Data Integration is Critical to Sponsors & CROs.’ See you at @DrugInfoAssn, booth #1907!
https://t.co/fK6MMsVV6U
#clinicaltrials
To make #clinicalresearch truly patient-centric, today we announce the launch of Patient Burden Index (PBI), which uses a data-driven approach to provide objective insight when creating trial protocols to improve study retention and recruitment #DIA2018
https://t.co/5PlKRRUJ5v